Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

FHLC vs. MEDX: which is better?

Bottom line

FHLC vs MEDX: the short answer

FHLC (Fidelity MSCI Health Care Index ETF) and MEDX (Horizon Kinetics Medical ETF) share a meaningful slice of their top holdings — about 48% by weight.

But FHLC is far broader, holding 337 positions to 33 for MEDX, so beyond the top names it adds exposure MEDX doesn't have.

FHLC is cheaper at 0.084% vs 0.85% — a difference of $77 a year per $10,000 invested.

Over five years, FHLC returned +7.2% a year vs +5.8% for MEDX (reporting dates differ).

Updated Nov 19, 2026

FHLC vs MEDX side by side

FHLCMEDX
TypeETFETF
Fund familyFidelityRoundhill
CategoryHealth Care SectorHealth Care Sector
Expense ratio0.084%0.85%
Annual cost per $10k$8.4$85
10-yr cost on $10k (prospectus)$108$1,049
Max front loadNoneNone
12b-1 fee0%0%
1-yr return+2.6%+28.4%
5-yr return (annualized)+7.2%+5.8%
10-yr return (annualized)+8.8%+5.7%
Best quarter+16.4%+15.0%
Worst quarter−13.1%−12.9%
Net assets (fund)$3.3B$19.1M
Number of holdings33733
Portfolio turnover3%%
Returns as ofNov 30, 2025Dec 31, 2025

Source: SEC Form N-PORT and fund prospectuses

Year-by-year returns

YearFHLCMEDXDifference
2024+2.6%−4.7%+7.3%
2023+2.5%−6.0%+8.5%
2022−5.5%+4.2%−9.7%
2021+20.4%+10.6%+9.8%
2020+18.1%+9.0%+9.1%
2019+21.9%+16.0%+5.9%
2018+5.5%+1.7%+3.9%
2017+23.3%+10.7%+12.6%
2016−3.3%−8.0%+4.7%

Source: Fund prospectus bar charts

Holdings overlap

8 of FHLC's top 25 holdings also appear in MEDX's top 25.

Shared top holdings
HoldingFHLCMEDX
Eli Lilly & Co13.35%18.46%
Johnson & Johnson8.93%5.59%
AbbVie Inc6.42%8.85%
Merck & Co Inc4.66%3.96%
Amgen Inc3.00%3.91%
Pfizer Inc2.06%2.86%
Bristol-Myers Squibb Co1.93%4.42%
Regeneron Pharmaceuticals Inc1.15%2.06%

Source: SEC Form N-PORT

FHLC top 10

  1. Eli Lilly & Co — 13.35%
  2. Johnson & Johnson — 8.93%
  3. AbbVie Inc — 6.42%
  4. UnitedHealth Group Inc — 5.44%
  5. Merck & Co Inc — 4.66%
  6. Thermo Fisher Scientific Inc — 3.09%
  7. Amgen Inc — 3.00%
  8. Abbott Laboratories — 2.66%
  9. Gilead Sciences Inc — 2.34%
  10. Pfizer Inc — 2.06%

MEDX top 10

  1. Eli Lilly & Co — 18.46%
  2. US Bank Mmda - Usbgfs 7 — 9.19%
  3. AbbVie Inc — 8.85%
  4. Novartis AG — 6.89%
  5. Johnson & Johnson — 5.59%
  6. Alkermes PLC — 5.53%
  7. AstraZeneca PLC — 4.98%
  8. Ionis Pharmaceuticals Inc — 4.53%
  9. Bristol-Myers Squibb Co — 4.42%
  10. Merck & Co Inc — 3.96%

FAQ

What is the difference between FHLC and MEDX?
FHLC (Fidelity MSCI Health Care Index ETF) and MEDX (Horizon Kinetics Medical ETF) share a meaningful slice of their top holdings — about 48% by weight. But FHLC is far broader, holding 337 positions to 33 for MEDX, so beyond the top names it adds exposure MEDX doesn't have.
Which is cheaper, FHLC or MEDX?
FHLC has the lower expense ratio (0.084%).
Should I own both FHLC and MEDX?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.

Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.